S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity by Cheng Deng (416051)

Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.). by Chang-Rui Chen (467755)

“…The increase in EEG amplitude may be interpreted as synchronization and a decrease in EEG can be interpreted as a desynchronization. …”

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

“…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”

Data for predator-induced defense decreases growth rate and photoprotective capacity in a nitrogen-limited dinoflagellate by Jingjing Zhang (17584605)

Regression Results for Average Antibiotic Resistance. by Peter Collignon (704972)

Subjects:

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene by Muhammad Idrees (92773)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene by Muhammad Idrees (92773)

Dysfunction of <i>ERG251</i> activates a Zinc transporter contributing to decreased azole susceptibility. by Xin Zhou (54275)

Supplementary Material for: Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis by Yao G.-Y. (4139125)

“…Treatment might provide a significant benefit but only when therapy lasts more than 6 months.…”

Expression of human PON1 decreases superoxide levels in <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production <i>in vitro</i> is correlated with decreased virulence in diverse clinical isolates in osteomyelitis by Mara J. Campbell (14579826)

“…We also showed that mutation of <i>sarA</i> results in a greater increase in protease production, and decrease in biofilm formation, than mutation of the loci encoding any of these other proteins. …”

<i>mbtK</i> deletion decreases phospholipid abundance during iron starvation. by Cressida A. Madigan (713924)

SPARC overexpression promotes AC invasion by decreasing type IV collagen levels in the BM. by Meghan A. Morrissey (2541352)

AA-deficient <i>sfx</i> mice had decreased articular cartilage. by Richard C. Lindsey (7148168)

Foxo1 decreases <i>SCN5a</i> promoter activity. by Weike Mao (181121)

APB5, but not APA5, decreases proliferating cell numbers in inter-alveolar spaces of lungs. by Masami Kishi (6167105)

Weight related parameters of subjects carrying (heterozygote) <i>NR5A1</i> mutations. by Jana Malikova (615672)

Subjects:

p7 ATMI mutant viruses display increased E2 secretion and decreased RNA and core secretion. by Solène Denolly (4692070)